GROUP ONE TRADING, L.P. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 68 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$14,300
-35.0%
129,411
-2.4%
0.00%
Q3 2022$22,000
-37.1%
132,611
-5.5%
0.00%
Q2 2022$35,000
-47.8%
140,311
+11.4%
0.00%
Q1 2022$67,000
-39.6%
125,911
-30.0%
0.00%
Q4 2021$111,000
-22.9%
179,987
+27.7%
0.00%
Q3 2021$144,000
-2.7%
140,970
+74.5%
0.00%
Q2 2021$148,000
-43.3%
80,770
-39.1%
0.00%
Q1 2021$261,000
+38.8%
132,676
-11.9%
0.00%
Q4 2020$188,000
-80.5%
150,616
-71.9%
0.00%
-100.0%
Q3 2020$966,000
+19.6%
536,655
+457.2%
0.00%
-25.0%
Q2 2020$808,000
+8.7%
96,310
-32.1%
0.00%
-33.3%
Q1 2020$743,000
+240.8%
141,823
+255.5%
0.01%
+500.0%
Q4 2019$218,000
+12.4%
39,898
+0.3%
0.00%
-50.0%
Q3 2019$194,000
-48.3%
39,798
-26.5%
0.00%
-33.3%
Q2 2019$375,000
-42.4%
54,111
-42.2%
0.00%
-57.1%
Q1 2019$651,000
+102.8%
93,643
+70.6%
0.01%
+133.3%
Q4 2018$321,000
+179.1%
54,887
+259.7%
0.00%
+200.0%
Q3 2018$115,000
+180.5%
15,258
+88.5%
0.00%
Q2 2018$41,000
-72.5%
8,094
-66.8%
0.00%
-100.0%
Q1 2018$149,000
-68.0%
24,363
-62.8%
0.00%
-66.7%
Q4 2017$465,000
+48.6%
65,551
+49.6%
0.00%0.0%
Q3 2017$313,000
+233.0%
43,816
+194.3%
0.00%
+200.0%
Q2 2017$94,00014,8900.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders